Literature DB >> 5473580

Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation.

S Mellander, I Nordenfelt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5473580     DOI: 10.1042/cs0390183

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  31 in total

1.  Dihydroergotamine and intracranial pressure.

Authors:  L Beretta
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".

Authors:  Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  The "Lund Concept" for the treatment of severe head trauma--physiological principles and clinical application.

Authors:  Per-Olof Grände
Journal:  Intensive Care Med       Date:  2006-08-02       Impact factor: 17.440

4.  The effects of dihydroergotamine in patients with head injury and raised intracranial pressure.

Authors:  P O Grände
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

5.  The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Authors:  V V Kakkar
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

6.  The effects of hydergine on acutely denervated cat skeletal muscle vasculature.

Authors:  D A Owen; E Stürmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing.

Authors:  H de Marées; D Welzel; A de Marées; U Klotz; K U Tiedjen; G Knaup
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Maximum oxygen consumption rate and dihydrogenated ergot alkaloids in humans.

Authors:  T Ingemann-Hansen; J Halkjaer-Kristensen
Journal:  Br J Sports Med       Date:  1984-06       Impact factor: 13.800

9.  Dihydroergotamine decreases the blood content in the skeletal musculature but etilefrine hydrochloride in the splanchnic region in man.

Authors:  J O Arndt; A Höck; K Inoue
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

10.  Bioavailability of dihydroergotamine in man.

Authors:  P J Little; G L Jennings; H Skews; A Bobik
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.